Harnessing the therapeutic potential of phytochemicals in neuroblastoma
Citations Over Time
Abstract
Neuroblastomas are the most common solid tumors outside of the brain that originate from immature neural crest cells, accounting for about 10% of all pediatric malignancies. The treatment for neuroblastomas involves a multimodal schedule, including surgery, radiation, chemotherapy, and immunotherapy. All these modalities are limited by side effects that might be severe, poor prognosis, and a high risk of recurrence. In the quest for additional therapeutic approaches, phytochemicals have attracted attention owing to their reported antitumor properties, safety, and multimechanistic mode of action. Several studies have used plant-derived bioactive compounds such as phenolics and flavonoids, suggesting modulation of biomolecules and signal transduction pathways involved in neuroblastoma. We reviewed the findings of recent preclinical and clinical studies demonstrating the effects of phytochemicals on neuroblastoma, shedding light on their molecular mechanism of action and potential therapeutic applications.
Related Papers
- → The MYCN Enigma: Significance of MYCN Expression in Neuroblastoma(2006)88 cited
- → The Characteristics of Mediastinal Neuroblastoma(2000)40 cited
- Biological characteristics of N-myc amplified neuroblastoma in patients over one year of age.(1988)
- → Excretion of catecholamines, their precursors and metabolites in patients with neuroblastoma and Ewing's tumour(1978)1 cited
- Current Clinical Trials in Neuroblastoma(2002)